Medical marijuana research bill passes in both chambers of Congress
The Senate unanimously approved a bill allowing medical marijuana research to expand on Wednesday. The bill is the first marijuana-related bill to be approved by both chambers of Congress, as the House unanimously passed the bill in July, Politico reports.
The unanimous votes in both chambers underscore the shift in sentiments about cannabis as the substance becomes increasingly mainstream. A recent Gallup poll found that support for marijuana legalization has maintained a record high of 68 percent since last year. In terms of partisan support, 83 percent of Democrats support legalization. In contrast, Republicans remain split, with 50 percent supporting legislation.
The bill, sponsored by Sen. Dianne Feinstein (D-Calif.) and Rep. Earl Blumenauer (D-Ore.), will make it easier for scientists to research medical marijuana. It will also protect doctors who discuss medical cannabis with their patients. Marijuana is still considered a Schedule 1 controlled substance, which denotes a high risk for addiction and a lack of medical benefits. While many states have legalized recreational and medical use on a local level, federal law has restricted the bounds of research into the substance's medical potential. Blumenauer told Politico that after decades of working on cannabis reform, "finally the dam is starting to break."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The bill will proceed to the desk of President Biden, who recently pardoned thousands of people convicted of low-level marijuana-related offenses. Biden also instructed the Department of Health and Human Services to review available research on marijuana.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
The best homes of the yearFeature Featuring a former helicopter engine repair workshop in Washington, D.C. and high-rise living in San Francisco
-
Critics’ choice: The year’s top 10 moviesFeature ‘One Battle After Another’ and ‘It Was Just an Accident’ stand out
-
The small Caribbean island courting crypto billionsUnder the Radar Crypto mogul Olivier Janssens plans to create a libertarian utopia on Nevis
-
Trump HHS moves to end care for trans youthSpeed Read The administration is making sweeping proposals that would eliminate gender-affirming care for Americans under age 18
-
Why does Trump want to reclassify marijuana?Today's Big Question Nearly two-thirds of Americans want legalization
-
Jack Smith tells House of ‘proof’ of Trump’s crimesSpeed Read President Donald Trump ‘engaged in a criminal scheme to overturn the results of the 2020 presidential election,’ hoarded classified documents and ‘repeatedly tried to obstruct justice’
-
House GOP revolt forces vote on ACA subsidiesSpeed Read The new health care bill would lower some costs but not extend expiring Affordable Care Act subsidies
-
Hegseth rejects release of full boat strike footageSpeed Read There are calls to release video of the military killing two survivors of a Sept. 2 missile strike on an alleged drug trafficking boat
-
Trump vows naval blockade of most Venezuelan oilSpeed Read The announcement further escalates pressure on President Nicolás Maduro
-
Kushner drops Trump hotel project in SerbiaSpeed Read Affinity Partners pulled out of a deal to finance a Trump-branded development in Belgrade
-
Senate votes down ACA subsidies, GOP alternativeSpeed Read The Senate rejected the extension of Affordable Care Act tax credits, guaranteeing a steep rise in health care costs for millions of Americans
